Syed Akif Uddin
INTRODUCTION
Antibiotic was seeing wonder drugs when they appeared because antibiotic can treat every infection. As soon, it was observed that the treated bacteria can build resistance in contrast to them and the resistance can be intrinsic or acquired [1]. The antibiotics are chemical compounds, which minimize the production of microorganism & ultimately kill microorganism. Natural fermentation or chemical synthesis may help in the production of these drugs. The antibiotics are the drugs, which are obtained from the compounds by different microbial flora. It is also noted that not every antibacterial compounds are antibiotics and obtained completely by chemical synthesize [2]. Though moldy materials helped in healing the wounds and infections, but it was observed in late 19th century that this was due to the microbes. Fleming’s, Chain’s and Florey’s clinical observations, development studies made a new innovation in antibiotics in the twenty century [2].
The new addition in the antimicrobial world is the oxazolidinone group of antibiotics which can play various significant roles in order to combat the infections occurred by Gram positive bacteria. The oxazolidinone provides greater result in contrast to Gram positive microorganisms and produces high resistance against microbial in clinical situations. Oxazolidinone is very useful and also shows a moderate microbial effectiveness in contrast to Gram negative bacteria.
Oxazolidinone substances are structurally available with 2-oxazolidinone. Oxazolidinone antibacterial compounds were seen problematic because they produced toxic effects in clinical studies. After few years oxazolidinone class was studied more for enhancing efficacy and safety, with the introduction of two vital and useful compounds like Eperezolid and Linezolid. Bioactive and toxic examination of both of a Linezolid and Eperezolid were almost same, so clinical testing was performed.
Linezolid
Linezolid chemically known as S – N - [ 3 - [ 3 – Fluoro – 4 - (4 – morpholinyl) phenyl] – 2 – oxo - 5 – oxazolidinyl] methyl] –Acetamide [4].Linezolid was recently registered for use clinically in more than fifty countries. Food drug administration (FDA) allowed indications include Vancomycin-resistant enterococci infections, consisting bacteremia, nosocomial pneumonia occurred by Staphylococcus aureus and Streptococcus pneumoniae, complicated skin and skin structure infections occurred by Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus agalactiae, uncomplicated skin and skin structure infections occurred by Staphylococcus aureus, and community acquired pneumonia from Streptococcus pneumoniae and or Staphylococcus aureus.There are various phases like phase II and III trials assessing Linezolid activity in these infections [5]. Previous investigations evaluated that Linezolid was very effective in terms of a number of significant gram positive cocci, like Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus species, and streptococci [6]. The invitro investigation of Linezolid and eperezolid demonstrated that resistance take place hardly by simple mutation in Staphylococcus aureus and include few problems or create no issue with adopted antimicrobial force, with a spiral gradient protocol [6]. The recent demonstration of a process to Linezolid acquired resistance, [8] evaluated that Linezolid or Eperezolid -resistant E. faecalis and S. aureus isolates of from laboratory origin resulted single G → U mutation at area 2447 / 2576 of the central loop of domain V of twenty three S rRNA [9]. The antibacterial treatment helps the body to terminate infectious microorganisms without producing any toxic effect to the host. The patient’s natural defense process should be known to avoid the infections [2]. Generally, antibacterial are classified on the basis of their mode of action, their bacteriostatic and bactericidal activity. Actually, the inhibition method of bacteriostatic substances involves inhibition of protein synthesis or few bacterial metabolic passages. Researchers assessed the in vitro studies in contrast fifty four methicillin-resistant Staphylococcus aureus (MRSA) strains using agar dilution method in conjunction with scanning electron microscopy of only Linezolid and in combination of vancomycin or teicoplanin. Their study revealed that Linezolid as a single agent over vancomycin and teicoplanin in contrast to MRSA isolates. Linezolid and vancomycin shows better activity than Linezolid and teicoplanin at all concentrations [11]. The comparison of Minimum inhibitory concentrations and Disc inhibition zones was done as per suggested by the National Committee for Clinical Laboratory Standards and the British Society for Antimicrobial Chemotherapy for one ninety eight strains of gram-positive cocci. Zones were found to be 4-5 mm larger by the British Society for Antimicrobial Chemotherapy process, but MICs showed no variations, except for pneumococci, which was found to be very sensitive when the British Society for Antimicrobial Chemotherapy method was utilized. The activity of Linezolid depresses due to the incubation in CO2 against this species only [12].
ANTIBIOTIC SUSCEPTIBILITY TESTING
The most common laboratory test to determine the effectiveness of antimicrobials is the susceptibility that evaluates the ability of an antibiotic to inhibit the growth of microorganisms. Susceptibility test is performed in order to recommend the physicians / pharmacist to select ideal and best antibiotic for a particular patient and to collect the epidemiological data within the society [13]. Antimicrobial susceptibility testing methods are classified depend on the principle applied in each system. They include:
Disc Diffusion Method
The agar diffusion test (Kirby–Bauer antibiotic testing, KB testing, or disc diffusion antibiotic sensitivity testing) is a test used to determine the of antibiotic. With the help of antibiotic discs, the bactericidal or bacteriostatic nature of the antibiotics can be measured. The method is divided into two types:
I-Kirby-Bauer method
II- Stokes method
KB testing is basically base on antibiotic permeated disc, which was implanted on agar already inoculated with bacteria. The moisture was picked up and diffused the antibiotic rapidly through the agar medium, resulting in antibiotic concentration gradient. The concentration of antibiotic at the corner of the disc is greater and constantly lower where the distance from the disc enhances to mark. At this area it is no longer shows any inhibitory response for the organism, so it then grows easily. A visible zone appears around an antibiotic disc after incubation, if the compound suppresses bacterial growth. [14]. KB testing is done with Mueller Hinton Agar for susceptibility test on a regularly basis due to the better reproducibility, low in sulphonamide, trimethoprim, and tetracycline inhibitors, and shows adequate growth of most bacterium. KB testing Inoculum was made with appropriate broth like Trypticase soya broth. The medium was manufactured followed the guidelines of manufacturer’s, dispenses in tubes at 4-5 ml and sterilized [14].
METHODOLOGY
The current study was studied in Department of Pharmaceutics, Federal Urdu University. Linezolid discs were purchased by Musajee Adam and Sons Company while 70% Isopropyl Alcohol, Sterile Distilled Water (WFI), Nutrient broth, Mueller- Hinton Broth (MHB) were also used. The interest of this study was to perform antibiotic susceptibility test in order to establish the in – vitro activity of Linezolid against infection caused by Staphylococcus aureus and Escherichia coli.
Preparation of Agar Media
Inoculum Preparation
At adequate turbidity, bacterial culture suspension was made and incubated as well as to standardize the Inoculum density 0.5 McFarland was used.
Steps Involved in Kirby–Bauer Method
RESULT
The antibacterial activity of Linezolid disc against different isolates of staphylococcus aureus and Escherichia coli was shown in Table 1
Table1. Result of antibacterial activity of Linezolid Disc against two isolates of different bacteria.
Isolates |
Disc Content |
Susceptible (S) |
Resistance (R) |
Intermediate (I) |
Staphylococcus aureus |
30 µg |
26 |
- |
- |
Staphylococcus aureus |
30 µg |
22 |
- |
- |
Escherichia coli |
30 µg |
21 |
- |
- |
Escherichia coli |
30 µg |
- |
18 |
- |
*Staphylococcus aureus showed susceptibility and zones were found to be 26mm and 22mm, while Escherichia coli showed susceptibility as well as resistance and zones were found to be 21mm and 18mm respectively.
Linezolid disc showed diameters of zone inhibition (susceptible / resistance) in a range of 18-26 against different bacterial strains which is as per CLSI standard. The results achieved from Linezolid disc showed susceptibility to two isolates of staphylococcus aureus and one isolate of Escherichia coli. Moreover Linezolid disc showed resistance against one isolate of Escherichia coli as well.
DISCUSSION
Assessment of antimicrobial susceptibility testing study indicated that Linezolid is very effective and helpful to treat infections caused by gram positive and gram negative bacteria.
The important function of the clinical microbiology laboratory is the role of antimicrobial testing of bacterial isolates. The main purpose of this testing is to evaluate the resistance of certain bacteria against the drug and to observe whether the particular bacterial isolate is susceptible, resistant or bactericidal against the infections. The most important benefit of Disc diffusion method is that it is very simple and it does not require any distinctive equipment, the clinicians can easily elucidate the results and also the selection of this method is flexible [16
Share this article